Skip to main content

Table 2 Efficacy of CT lymph node MAD and/or serum SCC-Ag in judging retroperitoneal lymph node metastasis in patients with locally advanced cervical squamous cell carcinom

From: Assessment of retroperitoneal lymph node status in locally advanced cervical cancer

Group Case Pathological results Accuracy (%) Sensitivity(%) Specificity (%) Youden index
Positive Negative
CT lymph node MAD ≥1.0 cm + SCC-Ag ≥ 5.2 ng/mL 24 24 0 75.71* 58.54 100.0* 0.59*
CT lymph node MAD ≥1.0 cm 40 33 7 72.09 66.0 80.56 0.47
SCC-Ag ≥ 5.2 ng/mL 39 30 9 71.43 73.17 68.97 0.42
  1. CT computed tomography, MAD minimum axial diameter, SCC-Ag Squamous cell carcinoma antigen. *P  < 0.05 vs. the CT lymph node MAD ≥1.0 cm group and SCC-Ag ≥ 5.2 ng/mL group